ArticleBMC pediatrics2022

Mortality reduction in pediatric patients with severe fatal human adenoviral pneumonia treated with high titer neutralizing antibodies (NAbs) plasma: a retrospective cohort study.

Hongyan Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.